Literature DB >> 11134300

Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.

R J Kraus1, S J Mirocha, H M Stephany, J R Puchalski, J E Mertz.   

Abstract

Epstein-Barr virus (EBV) is a human herpesvirus capable of establishing a latent state in B lymphocytes. EBV's BZLF1 gene product plays a central role in regulating the switch from latency to productive infection. Here, we identify a sequence element, 5'-CAGGTA-3', called ZV, located at nucleotides -17 to -12 relative to the transcription initiation site of the BZLF1 promoter. ZV sequence-specifically binds a cellular nuclear factor(s), ZVR. ZVR DNA-binding activity was present in the EBV-negative B-lymphocytic cell line DG75, the EBV-positive B-lymphocytic cell lines GG68 and 721, the cervical cell line C33A, and the kidney cell line CV-1 but not in the breast carcinoma cell line MCF-7. Mutations in ZV that relieve binding of ZVR lead to a two- to fourfold increase in basal expression of the BZLF1 promoter in DG75, C33A, and CV-1 cells. The same mutants exhibited a 40- to 180-fold increase in tetradecanoyl phorbol acetate-ionomycin-induced expression in DG75 cells and a 22-fold increase in C33A cells. Thus, ZVR functions as a regulator of the BZLF1 promoter, repressing transcription when bound to the ZV site in the absence of inducers. No differences in basal or induced transcription between wild-type and ZV mutant BZLF1 promoters were observed in ZVR-negative MCF-7 cells. ZVR failed to bind any of the previously identified negative regulatory elements within the BZLF1 promoter. We conclude that ZV functions as an important regulatory element of the BZLF1 promoter, with ZVR likely playing important roles in the maintenance of latency and reactivation of EBV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134300      PMCID: PMC113983          DOI: 10.1128/JVI.75.2.867-877.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells.

Authors:  B Kallin; J Luka; G Klein
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

2.  Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.

Authors:  J Luka; B Kallin; G Klein
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

3.  Activation of latent Epstein-Barr virus by antibody to human IgM.

Authors:  M G Tovey; G Lenoir; J Begon-Lours
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

4.  The late spliced 19S and 16S RNAs of simian virus 40 can be synthesized from a common pool of transcripts.

Authors:  P J Good; R C Welch; W S Ryu; J E Mertz
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  Prevalence, incidence and persistence of EB virus antibody in young adults.

Authors:  J C Niederman; A S Evans; L Subrahmanyan; R W McCollum
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

6.  Epstein-Barr virus induction by a serum factor. I. Induction and cooperation with additional inducers.

Authors:  G Bauer; P Höfler; H Zur Hausen
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

7.  Epstein-Barr virus with heterogeneous DNA disrupts latency.

Authors:  G Miller; M Rabson; L Heston
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells.

Authors:  P Kavathas; F H Bach; R DeMars
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters.

Authors:  R Weigel; G Miller
Journal:  Virology       Date:  1983-03       Impact factor: 3.616

View more
  22 in total

1.  Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes.

Authors:  Hans Helmut Niller; Daniel Salamon; Jörg Uhlig; Stefanie Ranf; Marcus Granz; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus.

Authors:  Richard J Kraus; Jacqueline G Perrigoue; Janet E Mertz
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Promoter sequences required for reactivation of Epstein-Barr virus from latency.

Authors:  Ulrich K Binné; Wolfgang Amon; Paul J Farrell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines.

Authors:  Adrienne L McNees; Jeff A Mahr; David Ornelles; Linda R Gooding
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.

Authors:  Amy L Ellis; Zhenxun Wang; Xianming Yu; Janet E Mertz
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

6.  Lytic cycle gene regulation of Epstein-Barr virus.

Authors:  Wolfgang Amon; Ulrich K Binné; Helen Bryant; Peter J Jenkins; Claudio Elgueta Karstegl; Paul J Farrell
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.

Authors:  Jian Huang; Gangling Liao; Honglin Chen; Frederick Y Wu; Lindsey Hutt-Fletcher; Gary S Hayward; S Diane Hayward
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency.

Authors:  Helen Bryant; Paul J Farrell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.

Authors:  Kelly L Gorres; Derek Daigle; Sudharshan Mohanram; George Miller
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.

Authors:  Frederick Y Wu; Shizhen Emily Wang; Honglin Chen; Ling Wang; S Diane Hayward; Gary S Hayward
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.